Concepedia
Statistics
Publications
3
Citations
234
H-Index
Active since
2014
Affiliations
Otsuka (United States)(Current)
Otsuka Pharmaceutical (Spain)
Agnes Elekes is an author at Otsuka (United States) specializing in medicine, pharmacology, and cancer pharmacology.
Publications per year
2014–2018
Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors
Johanna C. Bendell, David S. Hong, Howard A. Burris et al. · Cancer Chemotherapy and Pharmacology · 2014 · 111 citations
Medicine, Pharmacokinetics, Pharmacology +5
Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancer
T.R. Jeffry Evans, Eric Van Cutsem, Michael J. Moore et al. · Annals of Oncology · 2016 · 67 citations · Full text
Medicine, Oncology, Pharmacology +9
A First-in-Human Phase I Study of OPB-111077, a Small-Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers
Anthony W. Tolcher, Keith T. Flaherty, Geoffrey I. Shapiro et al. · The Oncologist · 2018 · 56 citations · Full text
Medicine, Oncology, Pharmacology +8
1–3 of 3